Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 295

1.

Is antiretroviral therapy during pregnancy associated with an increased risk of preterm delivery, low birth weight, or stillbirth?

Cotter AM, Garcia AG, Duthely ML, Luke B, O'Sullivan MJ.

J Infect Dis. 2006 May 1;193(9):1195-201. Epub 2006 Mar 28.

PMID:
16586354
2.

Antiretroviral therapy during pregnancy and the risk of an adverse outcome.

Tuomala RE, Shapiro DE, Mofenson LM, Bryson Y, Culnane M, Hughes MD, O'Sullivan MJ, Scott G, Stek AM, Wara D, Bulterys M.

N Engl J Med. 2002 Jun 13;346(24):1863-70.

3.

Declines in low birth weight and preterm birth among infants who were born to HIV-infected women during an era of increased use of maternal antiretroviral drugs: Pediatric Spectrum of HIV Disease, 1989-2004.

Schulte J, Dominguez K, Sukalac T, Bohannon B, Fowler MG; Pediatric Spectrum of HIV Disease Consortium.

Pediatrics. 2007 Apr;119(4):e900-6. Epub 2007 Mar 12.

PMID:
17353299
4.

Maternal antiretroviral drugs during pregnancy and infant low birth weight and preterm birth.

Szyld EG, Warley EM, Freimanis L, Gonin R, Cahn PE, Calvet GA, Duarte G, Melo VH, Read JS; NISDI Perinatal Study Group.

AIDS. 2006 Nov 28;20(18):2345-53.

PMID:
17117021
5.
6.

Protease inhibitor-associated increased risk of preterm delivery is an immunological complication of therapy.

Fiore S, Ferrazzi E, Newell ML, Trabattoni D, Clerici M.

J Infect Dis. 2007 Mar 15;195(6):914-6; author reply 916-7. No abstract available.

PMID:
17299724
7.

Obstetric and perinatal complications in HIV-infected women. Analysis of a cohort of 167 pregnancies between 1997 and 2003.

Martí C, Peña JM, Bates I, Madero R, de José I, Pallardo LF, Arribas JR, Gonzalez-Garcia J, Gonzalez A, Vazquez JJ.

Acta Obstet Gynecol Scand. 2007;86(4):409-15.

PMID:
17486461
8.

Combination antiretroviral therapy in human immunodeficiency virus-infected pregnant women.

McGowan JP, Crane M, Wiznia AA, Blum S.

Obstet Gynecol. 1999 Nov;94(5 Pt 1):641-6.

PMID:
10546703
9.

Increased rate of prematurity associated with antenatal antiretroviral therapy in a German/Austrian cohort of HIV-1-infected women.

Grosch-Woerner I, Puch K, Maier RF, Niehues T, Notheis G, Patel D, Casteleyn S, Feiterna-Sperling C, Groeger S, Zaknun D; Multicenter Interdisciplinary Study Group Germany/Austria.

HIV Med. 2008 Jan;9(1):6-13. doi: 10.1111/j.1468-1293.2008.00520.x.

10.

Use of antiretroviral therapy in pregnant HIV-infected women and the risk of premature delivery: a meta-analysis.

Kourtis AP, Schmid CH, Jamieson DJ, Lau J.

AIDS. 2007 Mar 12;21(5):607-15. Review.

PMID:
17314523
11.

Premature delivery in HIV-infected women starting protease inhibitor therapy during pregnancy: role of the ritonavir boost?

Sibiude J, Warszawski J, Tubiana R, Dollfus C, Faye A, Rouzioux C, Teglas JP, Ekoukou D, Blanche S, Mandelbrot L.

Clin Infect Dis. 2012 May;54(9):1348-60. doi: 10.1093/cid/cis198. Epub 2012 Mar 28.

PMID:
22460969
12.

Extended antenatal use of triple antiretroviral therapy for prevention of mother-to-child transmission of HIV-1 correlates with favorable pregnancy outcomes.

Marazzi MC, Palombi L, Nielsen-Saines K, Haswell J, Zimba I, Magid NA, Buonomo E, Scarcella P, Ceffa S, Paturzo G, Narciso P, Liotta G.

AIDS. 2011 Aug 24;25(13):1611-8. doi: 10.1097/QAD.0b013e3283493ed0.

PMID:
21673553
13.

Antiretroviral therapy in pregnant women with advanced HIV disease and pregnancy outcomes in Abidjan, Côte d'Ivoire.

Ekouevi DK, Coffie PA, Becquet R, Tonwe-Gold B, Horo A, Thiebaut R, Leroy V, Blanche S, Dabis F, Abrams EJ.

AIDS. 2008 Sep 12;22(14):1815-20. doi: 10.1097/QAD.0b013e32830b8ab9.

PMID:
18753864
14.

The AmRo study: pregnancy outcome in HIV-1-infected women under effective highly active antiretroviral therapy and a policy of vaginal delivery.

Boer K, Nellen JF, Patel D, Timmermans S, Tempelman C, Wibaut M, Sluman MA, van der Ende ME, Godfried MH.

BJOG. 2007 Feb;114(2):148-55.

15.

Treatment with protease inhibitors and coinfection with hepatitis C virus are independent predictors of preterm delivery in HIV-infected pregnant women.

Ravizza M, Martinelli P, Bucceri A, Fiore S, Alberico S, Tamburrini E, Tibaldi C, Guaraldi G, Anzidei G, Maccabruni A, Crisalli MP, Floridia M; Italian Group on Surveillance on Antiretroviral Treatment in Pregnancy.

J Infect Dis. 2007 Mar 15;195(6):913-4; author reply 916-7. No abstract available.

PMID:
17299723
16.

Obstetric and newborn infant outcomes in human immunodeficiency virus-infected women who receive highly active antiretroviral therapy.

Haeri S, Shauer M, Dale M, Leslie J, Baker AM, Saddlemire S, Boggess K.

Am J Obstet Gynecol. 2009 Sep;201(3):315.e1-5. doi: 10.1016/j.ajog.2009.06.017.

PMID:
19733286
17.

Pregnancy outcome among HIV positive women receiving antenatal HAART versus untreated maternal HIV infection.

Joseph O, Biodun O, Michael E.

J Coll Physicians Surg Pak. 2011 Jun;21(6):356-9. doi: 07.2011/JCPSP.356359.

PMID:
21711992
18.

Mother-to-child HIV transmission despite antiretroviral therapy in the ANRS French Perinatal Cohort.

Warszawski J, Tubiana R, Le Chenadec J, Blanche S, Teglas JP, Dollfus C, Faye A, Burgard M, Rouzioux C, Mandelbrot L; ANRS French Perinatal Cohort.

AIDS. 2008 Jan 11;22(2):289-99.

PMID:
18097232
19.

Combination antiretroviral therapy and duration of pregnancy.

European Collaborative Study; Swiss Mother and Child HIV Cohort Study.

AIDS. 2000 Dec 22;14(18):2913-20.

20.

Improved obstetric outcomes and few maternal toxicities are associated with antiretroviral therapy, including highly active antiretroviral therapy during pregnancy.

Tuomala RE, Watts DH, Li D, Vajaranant M, Pitt J, Hammill H, Landesman S, Zorrilla C, Thompson B; Women and Infants Transmission Study.

J Acquir Immune Defic Syndr. 2005 Apr 1;38(4):449-73.

PMID:
15764963

Supplemental Content

Support Center